Home Webtool Download Documentation Contact

Targets of perturbagens

Perturbagen ID : CID57303

Perturbagen : (r-(e))-1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid; 1-[[[(1 r)-1-[3-[(1e)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid; Accel-montelukast sodium tablets; Ach-montelukast; Apo-montelukast; Auro-montelukast; Auro-montelukast chewable tablet; Bio-montelukast; Dom-montelukast; Dom-montelukast fc; Ipg-montelukast; Jamp-montelukast; Mar-montelukast; Mint-montelukast; Montelukast; Montelukast sodium; Montelukast sodium chewable; Montelukast sodium tablets; Montelukastum; Montélukast; Mylan-montelukast; Ntp-montelukast; Pendo-montelukast; Pendo-montelukast fc; Pms-montelukast; Pms-montelukast fc; Priva-montelukast fc; Q-montelukast; Ran-montelukast; Ratio-montelukast; Riva-montelukast; Riva-montelukast fc; Sandoz montelukast; Sandoz montelukast granules; Sandoz montelukast tablet; Singulair; Teva-montelukast; Uni-montelukast; Van-montelukast

Target	Effect	Reference
ALOX5	-1	CLUE; STITCH; DrugBank
CYP2C8	-1	CLUE; STITCH
CYSLTR1	-1	DrugBank; CLUE; STITCH
IL4	-1	STITCH
IL5	-1	STITCH
CCL11	2	STITCH